Egyptian Pharmaceuticals & Biotech Undervalued based on future growth

Results

0 new

Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)

2 companies

Egyptian International Pharmaceutical Industries

Market Cap: ج.م13.3b

Manufactures and sells pharmaceutical ampoules in Egypt and internationally.

PHAR

ج.م78.89

-0.1%

65.5%

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E)

Market Cap: ج.م6.3b

Produces and sells a range of branded generic pharmaceuticals, food supplements, veterinary products, and nutraceuticals in Egypt.

RMDA

ج.م3.13

-2.8%

27.1%